Owner Sanofi-Aventis Deutschland GmbH

Inventors Will, David William; Uhlmann, Eugen; Breipohl, Gerhard

Agent Watermark

Pub. Number AU-B-2001254795

PCT Pub. Number WO01/79216

Priority 10019135 18.04.00 DE

Filing date 7 April 2001

Wipo publication date 30 October 2001

Acceptance publication date 8 March 2007

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 31/16 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C08G 69/48 (2006.01) Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule

C12Q 1/04 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Determining presence or kind of micro-organism

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 21/78 (2006.01) Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible, or ultra-violet light

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 33/58 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving labelled substances